Pasithea Therapeutics Announces Successful Completion of PAS-004 Chronic Toxicity Studies
September 09, 2024 08:01 ET
|
Pasithea
Pasithea completes chronic toxicity studies for PAS-004, showing safety and potential for long-term use in NF1 and cancer treatment; Phase 1 trial ongoing
TES Honored by Receiving Several Prestigious Awards
May 31, 2022 23:31 ET
|
TES
SINGAPORE, June 01, 2022 (GLOBE NEWSWIRE) -- In April, the Edison Awards announced that TES's sustainable battery solutions would be honored with the 2022 Gold award in the Sustainability-Power...
ORION BIOTECHNOLOGY PRESENTING NEW DATA ON ITS LATEST BEST-IN-CLASS GPCR DRUG CANDIDATE
May 10, 2022 13:03 ET
|
Orion Biotechnology Canada Ltd.
Ottawa, Canada, May 10, 2022 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd, a drug discovery and development company unlocking the therapeutic potential of G Protein-Coupled Receptors (GPCRs),...
Genmab and Synaffix Enter into License Agreement for ADC Technology
January 04, 2022 09:00 ET
|
Genmab A/S
Media Release Synaffix to provide access to proprietary antibody-drug conjugate (ADC) technologiesGenmab secures rights for conducting research on ADCs against multiple drug targets with options for...
Best-in-Class Mobile-Enabled Sales Teams Achieved 109% of Quotas and Grew Revenue 16.7% According to Sage-Sponsored Aberdeen Research Brief
June 20, 2012 09:00 ET
|
Sage North America
SCOTTSDALE, AZ--(Marketwire - Jun 20, 2012) - Sage North America today announced availability of an Aberdeen Group Research Brief analyzing the sales mobility effectiveness and achievements of 250...
STATS ChipPAC Honoured by LSI With Three Outstanding Performance Awards Including Strategic Partner of the Year
June 01, 2011 13:00 ET
|
STATS ChipPAC
SINGAPORE--6/2/2011, UNITED STATES--(Marketwire - Jun 1, 2011) - STATS ChipPAC Ltd. ("STATS ChipPAC" or the "Company") (SGX-ST: STATSChP), a leading semiconductor test and advanced packaging service...